Evidence map›Paper›PMID 40768597›Full record

ArticleScience translational medicine2025

Regulatory KIR

Jing Li, Xuerui Wang, Andreas I Lackner, Purnima Narasimhan, Lin Li, Vamsee Mallajosyula, Mary M Johnson, Anna-Lena Höbler, Adam S Kirosingh, Amy E Braun and 13 more

Registry-linked trialAbstract read
In one paragraph

Article in Science translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04978272 (Enhancing Immunity to Malaria in Young Children With Effective Chemoprevention), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04978272 phase3active not recruitingnot on this map

Enhancing Immunity to Malaria in Young Children With Effective Chemoprevention

TypeinterventionalSponsorGrant Dorsey, M.D, Ph.D.Ran2022 to 2027Enrolled924ConditionsMalariaArmsDihydroartemisinin-piperaquine (DP), DP Placebo
3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. NK-like and networked CD8bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Donor-derived CD8bioRxiv : the preprint server for biology · 2026
    Article
  7. Review
  8. Article
  9. Regulatory KIRNature reviews. Immunology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Jing LiDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.ORCID 0000-0002-9285-9423
Xuerui WangDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.ORCID 0000-0001-6448-2676
Andreas I LacknerDepartment of Pathology, School of Medicine, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0002-8034-0181
Purnima NarasimhanDepartment of Obstetrics and Gynecology, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Lin LiDivision of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0001-8974-4636
Vamsee MallajosyulaInstitute of Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0002-0658-3652
Mary M JohnsonDepartment of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.
Anna-Lena HöblerDepartment of Obstetrics and Gynecology, Reproductive Biology Unit, Maternal-Fetal Immunology Group, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-5529-9378
Adam S KirosinghDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0003-0500-9269
Amy E BraunDepartment of Pathology, School of Medicine, Stanford University, Stanford, CA 94305, USA.
Felistas NankyaInfectious Diseases Research Collaboration, Kampala, Uganda.ORCID 0009-0004-6011-9801
Kenneth MusinguziInfectious Diseases Research Collaboration, Kampala, Uganda.
Abel KakuruInfectious Diseases Research Collaboration, Kampala, Uganda.ORCID 0000-0001-9941-1309
Moses KamyaInfectious Diseases Research Collaboration, Kampala, Uganda.ORCID 0000-0001-9106-4234
Philip J RosenthalDepartment of Medicine, University of California San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0002-7953-7622
Grant DorseyDepartment of Medicine, University of California San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0003-0740-0317
Prasanna JagannathanDepartment of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0001-6305-758X
Michael AngeloDepartment of Pathology, School of Medicine, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0003-1531-5067
Jürgen PollheimerDepartment of Obstetrics and Gynecology, Reproductive Biology Unit, Maternal-Fetal Immunology Group, Medical University of Vienna, 1090 Vienna, Austria.
Stephanie L GawDivision of Maternal Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, CA 94158, USA.ORCID 0000-0003-0891-6964
Virginia D WinnDepartment of Obstetrics and Gynecology, School of Medicine, Stanford University, Stanford, CA 94305, USA.ORCID 0000-0003-1136-2907
Kari C NadeauDepartment of Environmental Health, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.ORCID 0000-0002-2146-2955
Mark M DavisInstitute of Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0001-6868-657X

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CHRISTOPHER J. BAKKENIST · 1988 to 2026
$158.0M
University of Pittsburgh Clinical and Translational Science InstituteUL1TR001857 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2016 to 2025
$129.3M
Using a tonsil organoid system to probe conditions for the induction of protective antibody and T cell responses to influenza.U19AI057229 · NIAID · STANFORD UNIVERSITY · PI Mark Morris Davis · 2003 to 2026
$88.5M
Preeclampsia to cardiovascular disease: Life course analysis of biomarkers and riskR01HL139844 · NHLBI · STANFORD UNIVERSITY · PI HLATKY, MARK A., WINN, VIRGINIA D · 2018 to 2021
$9.0M
Enhancing immunity to malaria in young children with effective chemopreventionU01AI155325 · NIAID · STANFORD UNIVERSITY · PI JAGANNATHAN, PRASANNA · 2021 to 2025
$6.3M
Optimal chemopreventive regimens to prevent malaria and improve birth outcomes in UgandaU01AI141308 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DORSEY, MATTHEW G, ROSENTHAL, PHILIP JON · 2020 to 2024
$6.0M
Immune Tolerance Dysfunction in Pregnancy due to Ambient Air Pollution ExposureR01ES032253 · NIEHS · STANFORD UNIVERSITY · PI NADEAU, KARI C. · 2020 to 2024
$2.2M
Placental malaria: The role of inflammation at the maternal-fetal interfaceK08AI141728 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GAW, STEPHANIE LINA · 2019 to 2023
$950k
NCATS NIH HHS UL1 TR001857NCI NIH HHS P30 CA047904NHLBI NIH HHS R01 HL139844NIAID NIH HHS K08 AI141728NIAID NIH HHS U01 AI141308NIAID NIH HHS U01 AI155325NIAID NIH HHS U19 AI057229NIEHS NIH HHS R01 ES032253
6 · The paper itself

Abstract

During pregnancy, immune responses must balance protection from infections with tolerance of the semiallogeneic fetus. However, the mechanisms regulating maternal-fetal tolerance remain poorly understood. Recently, we identified CD8

Indexed as

CD8-Positive T-LymphocytesReceptors, KIRAdultDeciduaFemaleHumansImmune ToleranceMalePregnancyReceptors, KIR

Identifiers

PMID40768597
PMCPMC12696559

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.